How Can We Help You?

Quick Info:

Find a Doctor Specialties (800) 213-3284

Go To Home PageBack

Lung Cancer Trials

Select Clinical Trial

CALGB 30610: Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide

  • Men or women, ages 18 and older, diagnosed with limited-stage small-cell lung cancer. For additional criteria, call our Clinical Trials office at (910) 715-2200.

 

SWOG 1400: Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer

  • Men or women, ages 18 and older, diagnosed with squamous cell non-small cell lung cancer; disease must be either advanced, stage IIIB or IV. For additional criteria, call our Clinical Trials office at (910) 715-2200.

 

NRG-LU001: Chemotherapy and Radiation Therapy with or without Metformin Hydrochloride in Treating Patients with Stage III Non-small Cell Lung Cancer

  • Men or women, ages 18 and older, diagnosed with Stage IIIA or IIIB non-small cell lung cancer. For additional criteria, call our Clinical Trials office at (910) 715-2200.

 

RTOG 1306: Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer (NSCLC)

  • Men or women, ages 18 and older, newly diagnosed with Stage IIIA or IIIB non-squamous NSCLC.  For additional criteria, call our Clinical Trials office at (910) 715-2200.

 

ALCHEMIST: Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial

  • Men or women, ages 18 or older, diagnosed with Stage IIIA, II or large IB non-small cell lung cancer (NSCLC).  For additional criteria, call our Clinical Trials Office at (910) 715-2200.

 

GO29436 (IMpower150):A Phase III, Open-Label, Randomized Study of MPDL3280A (Anti-PD-L1 Antibody) In Combination With Carboplatin + Paclitaxel With or Without Bevacizumab Compared With Carboplatin + Paclitaxel + Bevacizumab In Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

  • Men or women, ages 18 or older, diagnosed with Stage IV non-small cell lung cancer (NSCLC).  For additional criteria, call our Clinical Trials Office at (910) 715-2200.

 

Checkmate 370: A Master Protocol of Phase 2 Studies of Nivolumab in Advanced NSCLC Using Nivolumab as Maintenance After Induction Chemotherapy or as First-line Treatment Alone or in Combination With Standard of Care Therapies

  • Men or women, ages 18 and older, diagnosed with locally advanced or stage IV non-small cell lung cancer. For additional criteria, call our Clinical Trials office at (910) 715-2200.
Specialties
Clara McLean House
Make a Donation
News & Events